| Citation: |
LI Zhimao, WANG Dandi, ZHANG Ting, MEI Qimin, LIU Yecheng, ZHU Huadong. Comparative Efficacy of Amiodarone and Lidocaine in Patients with Cardiac Arrest: A Systematic Review and Meta-analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 406-415. DOI: 10.12290/xhyxzz.2024-0840
|
To investigate the efficacy of amiodarone and lidocaine in cardiac arrest patients.
We searched the PubMed, Embase, Cochrane Library, and Web of Science databases through to January 1, 2024. All studies comparing lidocaine, amiodarone, and placebo for cardiac arrest were included. Meta-analysis was performed, and the primary outcome was survival to hospital discharge. Secondary outcomes was survival to 24 h or hospital admission.
Three RCTs and seven non-randomized intervention studies were included. Compared with placebo, amiodarone can improve the likelihood of survival to 24 h/hospital admission (OR=1.32, 95% CI: 1.12-1.54) in RCTs, while this significance was not found in non-randomized intervention studies (OR=0.79, 95% CI: 0.39-1.61). In both RCTs and non-randomized intervention studies, amiodarone did not significantly improve discharge survival rate compared with placebo (OR=1.19, 95% CI: 0.98-1.44 and OR=1.14, 95% CI: 0.44-2.99). Lidocaine was more effective than placebo in improving both survival to 24 h/hospital admission (OR=2.36, 95% CI: 1.47-3.80) and discharge from hospital (OR=2.10, 95% CI: 1.21-3.64) in non-randomized intervention studies. Amiodarone showed no significant difference in improving survival to 24 h/admission to hospital compared with lidocaine in RCTs, while amidoraone was inferior to lidocaine in improving 24 h/admission survival rate (OR=0.72, 95% CI: 0.53-0.98) and discharge survival rate (OR=0.81, 95% CI: 0.76-0.87)in non-randomized intervention study.
Limited RCTs directly compared amiodarone and lidocaine. No significant difference was found between amiodarone and lidocaine in improving 24 h/admission survival rate in RCTs. While compared to amiodarone and placebo, lidocaine can improve 24 h/admission survival rate and discharge survival rate in non-randomized intervention studies.
| [1] |
中国研究型医院学会心肺复苏学专业委员会. 2016中国心肺复苏专家共识[J]. 中华灾害救援医学, 2017, 5(1): 1-23.
Chinese Research Hospital Association Cardiopulmonary Resuscitation Professional Committee. 2016 National consensus on cardiopulmonary resuscitation in China[J]. Chin J Disaster Med, 2017, 5(1): 1-23.
|
| [2] |
Virani S S, Alonso A, Benjamin E J, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association[J]. Circulation, 2020, 141(9): e139-e596.
|
| [3] |
Andersen L W, Holmberg M J, Berg K M, et al. In-hospital cardiac arrest: a review[J]. JAMA, 2019, 321(12): 1200-1210. DOI: 10.1001/jama.2019.1696
|
| [4] |
Goodarzi A, Khatiban M, Abdi A, et al. Survival to discharge rate and favorable neurological outcome related to gender, duration of resuscitation and first document of patients in-hospital cardiac arrest: a systematic meta-analysis[J]. Bull Emerg Trauma, 2022, 10(4): 141-156.
|
| [5] |
Panchal A R, Berg K M, Kudenchuk P J, et al. 2018 American Heart Association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J]. Circulation, 2018, 138(23): e740-e749.
|
| [6] |
Kudenchuk P J, Cobb L A, Copass M K, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation[J]. N Engl J Med, 1999, 341(12): 871-878. DOI: 10.1056/NEJM199909163411203
|
| [7] |
Dorian P, Cass D, Schwartz B, et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation[J]. N Engl J Med, 2002, 346(12): 884-890. DOI: 10.1056/NEJMoa013029
|
| [8] |
Kudenchuk P J, Brown S P, Daya M, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest[J]. N Engl J Med, 2016, 374(18): 1711-1722. DOI: 10.1056/NEJMoa1514204
|
| [9] |
Sanfilippo F, Corredor C, Santonocito C, et al. Amiodarone or lidocaine for cardiac arrest: a systematic review and meta-analysis[J]. Resuscitation, 2016, 107: 31-37. DOI: 10.1016/j.resuscitation.2016.07.235
|
| [10] |
Khan S U, Winnicka L, Saleem M A, et al. Amiodarone, lidocaine, magnesium or placebo in shock refractory ventricular arrhythmia: a Bayesian network meta-analysis[J]. Heart Lung, 2017, 46(6): 417-424. DOI: 10.1016/j.hrtlng.2017.09.001
|
| [11] |
Zhao H L, Fan K, Feng G L. Amiodarone and/or lidocaine for cardiac arrest: a Bayesian network meta-analysis[J]. Am J Emerg Med, 2020, 38(10): 2185-2193. DOI: 10.1016/j.ajem.2020.06.074
|
| [12] |
Wang Q, Lin Z, Chen H R, et al. Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: a network meta-analysis[J]. Medicine (Baltimore), 2023, 102(15): e33195. DOI: 10.1097/MD.0000000000033195
|
| [13] |
Daya M R, Leroux B G, Dorian P, et al. Survival after intravenous versus intraosseous amiodarone, lidocaine, or placebo in out-of-hospital shock-refractory cardiac arrest[J]. Circulation, 2020, 141(3): 188-198. DOI: 10.1161/CIRCULATIONAHA.119.042240
|
| [14] |
Wagner D, Kronick S L, Nawer H, et al. Comparative effectiveness of amiodarone and lidocaine for the treatment of in-hospital cardiac arrest[J]. Chest, 2023, 163(5): 1109-1119. DOI: 10.1016/j.chest.2022.10.024
|
| [15] |
Page M J, McKenzie J E, Bossuyt P M, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews[J]. BMJ, 2021, 372: n71.
|
| [16] |
Sterne J A C, Savović J, Page M J, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials[J]. BMJ, 2019, 366: l4898.
|
| [17] |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605. DOI: 10.1007/s10654-010-9491-z
|
| [18] |
Herlitz J, Ekström L, Wennerblom B, et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?[J]. Resuscitation, 1997, 33(3): 199-205. DOI: 10.1016/S0300-9572(96)01018-0
|
| [19] |
Skrifvars M B, Kuisma M, Boyd J, et al. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest[J]. Acta Anaesthesiol Scand, 2004, 48(5): 582-587. DOI: 10.1111/j.0001-5172.2004.00386.x
|
| [20] |
Rea R S, Kane-Gill S L, Rudis M I, et al. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias[J]. Crit Care Med, 2006, 34(6): 1617-1623. DOI: 10.1097/01.CCM.0000217965.30554.D8
|
| [21] |
Tahara Y. Comparison of amiodarone and nifekalant for shock-resistant ventricular fibrillation: SOS-KANTO study[J]. Cardioangiology, 2010, 68: 253-261.
|
| [22] |
Amino M, Inokuchi S, Nagao K, et al. Nifekalant hydrochloride and amiodarone hydrochloride result in similar improvements for 24-hour survival in cardiopulmonary arrest patients: the SOS-KANTO 2012 study[J]. J Cardiovasc Pharmacol, 2015, 66(6): 600-609. DOI: 10.1097/FJC.0000000000000310
|
| [23] |
Tagami T, Matsui H, Tanaka C, et al. Amiodarone compared with lidocaine for out-of-hospital cardiac arrest with refractory ventricular fibrillation on hospital arrival: a nationwide database study[J]. Cardiovasc Drugs Ther, 2016, 30(5): 485-491. DOI: 10.1007/s10557-016-6689-7
|
| [24] |
Panchal A R, Bartos J A, Cabañas J G, et al. Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J]. Circulation, 2020, 142(16_suppl_2): S366-S468.
|
| [25] |
王立祥. 中国心肺复苏发展战略观[J]. 中华危重病急救医学, 2015, 27(3): 161-163.
Wang L X. Strategic view on the development of cardiopulmonary resuscitation in China[J]. Chin Crit Care Med, 2015, 27(3): 161-163.
|
| [26] |
范国辉张林峰. 心源性猝死的流行病学研究进展[J]. 中华流行病学杂志, 2015, 36(1): 87-89.
Fan G H, Zhang L F. Sudden cardiac death: progress in epidemiological research[J]. Chin J Epidemiol, 2015, 36(1): 87-89.
|
| [1] | SUN Yuxin, HAN Bingtai, GUO Xiaoyuan, ZHENG Xueqing, CHEN Shi, YANG Hongbo, PAN Hui. Effect of Exercise on Blood Glucose Metabolism of Type 2 Diabetes Patients in East Asian Population: A Meta-Analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 492-505. DOI: 10.12290/xhyxzz.2024-0296 |
| [2] | SUN Yuxin, GUO Xiaoyuan, CHEN Shi, PAN Hui, ZHU Huijuan. Meta-Analysis of the Effect of Resistance Exercise Prescription on Glucose and Lipid Metabolism in Overweight and Obese Adults[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 235-247. DOI: 10.12290/xhyxzz.2024-0225 |
| [3] | CHEN Tianren, DU Zhongying, TANG Lu, CHEN Wenqiang, WANG Chun'ai. Effect of Erector Plane Muscle Block and Thoracic Paravertebral Block on Postoperative Analgesia in Patients with Breast Cancer: A Meta-analysis[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0351 |
| [4] | ZHAO Tingting, ZHAO Yuanyuan, XING Jihong. Analysis of Clinical Characteristics and Resuscitation Outcomes of Adult Patients with In-hospital Cardiac Arrest[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 536-542. DOI: 10.12290/xhyxzz.2022-0623 |
| [5] | LI Feng, WU Xinjie, CHEN Qijiang, LIU Ying, XU Jiefeng, ZHOU Guangju, ZHANG Mao. Effects of Artesunate on Lung Injury After Cardiac Arrest and Resuscitation in Pigs and Its Mechanism[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 520-527. DOI: 10.12290/xhyxzz.2022-0730 |
| [6] | LIU Hui, SU Renfeng, SHI Anya, YAO Yuanyuan, ZHOU Qi, WANG Zijun, TIE Rui, LU Mengying, ZHANG Hao, SUN Haonan, ZHAO Junxian, ZHAO Siya, YANG Kehu, LIU Xingrong, CHEN Yaolong. Methodological Quality Analysis of Systematic Review/Meta-analysis Published in Chinese Science Citation Database Journals[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 390-398. DOI: 10.12290/xhyxzz.2022-0317 |
| [7] | Yi-bing ZHU, Wei LI. How Do Clinicians Understand Meta-analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 314-319. DOI: 10.3969/j.issn.1674-9081.20200073 |
| [8] | Xiao-xia PENG. Methodological Limitations and Applicable Context of Meta-analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 381-386. DOI: 10.3969/j.issn.1674-9081.2017.06.012 |
| [9] | Xiao-feng LI, Chao-ji ZHANG, Jian-zhou LIU, Guo-tao MA, Xing-rong LIU, Qi MIAO. Correlation Between Blood Transfusion and Postoperative Outcomes following Cardiac Surgery: A Systematic Review[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(6): 426-431. DOI: 10.3969/j.issn.1674-9081.2016.06.005 |
| [10] | Ni XU, Cong-wei LIU, Fang-tian DONG. Dexamethasone Intravitreal Implant Compared with Anti-vascular Endothelial Growth Factor Injection for Macular Edema Secondary to Retinal Vein Occlusion: a Meta-analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(3): 168-175. DOI: 10.3969/j.issn.1674-9081.2016.03.002 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: